Could a new pill help clear stubborn lung infections?

NCT ID NCT07084402

Recruiting now Disease control Sponsor: Bin Cao Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 23 times

Summary

This study tests whether adding the drug contezolid to the usual treatment for MAC lung disease can lower bacteria levels more than standard care alone. About 188 adults with this chronic lung infection will take either the combination or standard drugs for 6 months. Researchers will track bacterial clearance and side effects to see if the new approach is safer and more effective.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beijing Chest Hospital, Capital Medical University
ACTIVE_NOT_RECRUITING

Beijing, Beijing Municipality, China
China-Japan Friendship Hospital
RECRUITING

Beijing, Beijing Municipality, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Jiangxi Provincial Chest Hospital
RECRUITING

Nanchang, Jiangxi, China

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

MYCOBACTERIUM AVIUM COMPLEX PULMONARY DISEASE